Peripheral Vascular Devices Market Advances as Healthcare Systems Increase Investment in Endovascular Care

Peripheral Vascular Devices Market Expansion Reflects Rising Burden of Peripheral Artery Disease and Continued Adoption of Minimally Invasive Interventions

The global Peripheral Vascular Devices market was valued at USD 11.85 Billion in 2025 and is projected to reach USD 23.53 Billion by 2035, registering a revenue CAGR of 7.1% during the forecast period, according to the latest analysis by Emergen Research.

VANCOUVER, British Columbia, June 22, 2026 - The global Peripheral Vascular Devices market, valued at USD 11.85 Billion in 2025, is expected to reach USD 23.53 Billion by 2035, reflecting continued demand for diagnostic and therapeutic technologies used in the treatment of peripheral vascular disorders. Rising prevalence of peripheral artery disease (PAD), diabetes, and an aging population are increasing the number of patients requiring vascular intervention. Wider adoption of minimally invasive procedures is supporting the use of angioplasty balloons, stents, atherectomy systems, and related vascular devices across hospitals and specialty care centers. According to the World Health Organization (WHO), noncommunicable diseases account for approximately 74% of global deaths, while cardiovascular diseases remain the leading cause of mortality worldwide, increasing demand for early diagnosis and vascular treatment solutions. In addition, data from the U.S. Centers for Disease Control and Prevention (CDC) indicate that millions of adults in the United States are affected by peripheral artery disease, particularly among older adults and individuals with diabetes or smoking history.

Increasing investments in vascular healthcare infrastructure and advances in endovascular technologies continue to improve clinical outcomes and procedural efficiency. Healthcare providers are adopting drug-coated balloons, drug-eluting stents, intravascular imaging systems, and advanced guidewire technologies to reduce complications and improve long-term vessel patency. Regulatory approvals for next-generation vascular devices are expanding treatment options across developed and emerging healthcare markets. For instance, in January 2025, Boston Scientific, United States, announced expanded clinical data supporting its peripheral intervention portfolio, reinforcing its focus on minimally invasive treatment options for peripheral artery disease. Growing awareness campaigns promoting early vascular disease diagnosis and government efforts to strengthen cardiovascular care services are also contributing to sustained market demand. These are some of the key factors driving revenue growth of the Peripheral Vascular Devices market.

Download a Sample: https://www.emergenresearch.com/request-sample/1829

However, high procedural costs and the expense of advanced vascular devices remain major challenges, particularly in low- and middle-income countries where reimbursement coverage is limited. Regulatory approval processes for implantable vascular devices require extensive clinical evidence, increasing product development timelines and costs. In addition, shortages of trained interventional specialists in several healthcare systems can limit access to advanced peripheral vascular procedures. These factors are expected to limit Peripheral Vascular Devices market growth to some extent over the forecast period.

The angioplasty balloons segment accounted for the largest share of the market due to their widespread use in treating peripheral artery disease through minimally invasive procedures. Balloon angioplasty remains one of the first-line treatment options because of its clinical effectiveness, shorter recovery times, and broad availability across healthcare facilities. Continuous improvements in drug-coated balloon technologies are also supporting adoption among physicians seeking to reduce restenosis rates.

The atherectomy devices segment is expected to register the fastest growth during the forecast period. Rising demand for plaque removal procedures in patients with heavily calcified lesions is increasing the use of directional, rotational, orbital, and laser atherectomy systems. Advances in imaging-guided interventions and physician preference for vessel preparation before stent placement are further supporting segment expansion.

North America accounted for the largest revenue share in the global Peripheral Vascular Devices market. High disease prevalence, favorable reimbursement systems, and rapid adoption of advanced vascular technologies continue to support regional growth. The United States remains the largest contributor due to strong clinical research activity and the presence of leading manufacturers including Medtronic, Boston Scientific, and Abbott. According to the CDC, peripheral artery disease affects approximately 6.5 million adults aged 40 years and older in the United States, supporting continued demand for vascular interventions.

Europe is expected to maintain a substantial market share due to expanding cardiovascular disease management programs and increasing adoption of minimally invasive treatment approaches. Countries including Germany, France, Italy, and the United Kingdom continue to invest in hospital modernization and advanced interventional cardiology services. The European Society of Cardiology (ESC) continues to promote evidence-based guidelines for the diagnosis and treatment of peripheral arterial diseases, encouraging wider clinical adoption of advanced peripheral vascular devices across the region.

Asia Pacific is expected to register the fastest revenue growth during the forecast period. Rapid growth in the elderly population, increasing diabetes prevalence, expanding healthcare infrastructure, and improving access to advanced medical technologies are driving demand across China, India, Japan, and South Korea. Government healthcare investments and increasing domestic medical device manufacturing are strengthening regional market development. Companies such as Terumo Corporation continue to expand their peripheral intervention portfolios while supporting physician training and technology adoption throughout Asia Pacific.

Peripheral Vascular Devices Market Segmentation Analysis

The Peripheral Vascular Devices Market is structured across the following key dimensions:

By Product Outlook (Revenue, USD Billion; 2024-2035)
Angioplasty Balloons

Peripheral Stents

Atherectomy Devices

Catheters and Guidewires

Embolic Protection Devices

Intravascular Lithotripsy and Thrombectomy Devices

By Indication Outlook (Revenue, USD Billion; 2024-2035)
Peripheral Artery Disease

Peripheral Venous Disease

By End User Outlook (Revenue, USD Billion; 2024-2035)
Hospitals

Ambulatory Surgical Centres and Office-Based Labs

Specialty Clinics

Regional Outlook (Revenue, USD Billion; 2024-2035)
North America (U.S., Canada, Mexico)

Europe (Germany, France, U.K., Italy, Rest of Europe)

Asia Pacific (China, Japan, India, South Korea, Rest of APAC)

Latin America (Brazil, Mexico, Rest of LATAM)

Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of MEA)

View Report: https://www.emergenresearch.com/industry-report/peripheral-vascular-devices-market

About Emergen Research

Emergen Research is a market research and consulting firm that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics and industries to help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market.

Media Contact

Contact Us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9

Eric Lee
Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

This release was published on openPR.